Technical Advantages and Clinical Value of Real-Time Fluorescent PCR for Detecting Mycobacterium tuberculosis Complex DNA

Working Principle and Kit Components

The Mycobacterium tuberculosis complex nucleic acid (DNA) detection kit (real-time fluorescent PCR method) is based on polymerase chain reaction (PCR) technology. Through the design of specific primers and fluorescent probes, it amplifies and detects conserved gene sequences of the Mycobacterium tuberculosis complex (including Mycobacterium tuberculosis, Mycobacterium bovis, etc.). The kit typically contains DNA extraction reagents, PCR reaction solution, positive control, negative control, and an internal standard system. In a real-time fluorescent PCR instrument, the reaction system completes denaturation, annealing, and extension under specific temperature cycles, and fluorescent signals are collected in real time as amplification products accumulate, thereby achieving qualitative or semi-quantitative detection of target DNA. This technology can effectively distinguish the Mycobacterium tuberculosis complex from non-tuberculous mycobacteria, avoiding cross-reactivity. The lower limit of detection commonly ranges from several hundred to several thousand copies per reaction, depending on product design. Before use, clinical laboratories must strictly validate the inter-batch and intra-batch precision of the kit and regularly participate in external quality assessment.

Role in Clinical Diagnosis

In global tuberculosis prevention and control, rapid and accurate etiological diagnosis is key to controlling transmission. Compared with traditional smear microscopy and culture methods, the Mycobacterium tuberculosis complex nucleic acid detection kit (real-time fluorescent PCR method) has the characteristics of a short detection cycle (usually results can be obtained in 2–4 hours) and high sensitivity, making it especially suitable for the auxiliary diagnosis of smear-negative pulmonary tuberculosis, extrapulmonary tuberculosis, and pediatric tuberculosis. At the same time, this kit can be combined with drug resistance gene detection to provide reference for clinical medication. However, it should be noted that a positive nucleic acid test cannot alone serve as the basis for diagnosing active tuberculosis and must be comprehensively judged in combination with clinical manifestations, imaging, and other laboratory tests. In addition, PCR inhibitors in samples or improper operation may lead to false-negative results, and laboratories should strictly follow the instructions for sample processing and amplification.

Quality Control and Precautions

To ensure the reliability of test results, when using the Mycobacterium tuberculosis complex nucleic acid (DNA) detection kit (real-time fluorescent PCR method), laboratories should establish and follow standardized operating procedures. Samples are mainly collected from sputum, bronchial lavage fluid, pleural effusion, etc., and after collection should be processed as soon as possible or stored according to the instructions. Each test should include a positive control, negative control, and internal standard control to monitor extraction efficiency, amplification reaction, and the normality of fluorescent signals. When interpreting results, if the internal standard is invalid or control results are abnormal, retesting is required. The kit should be used within its shelf life, and repeated freezing and thawing should be avoided. At the same time, laboratories should pay attention to false positives that may be caused by contamination with amplification products and adopt a unidirectional workflow and strict cleaning and disinfection measures. This kit is only an auxiliary diagnostic tool and cannot replace comprehensive clinical judgment.